Top 20 Deciphera Pharmaceuticals investors
The most complete profiles first. Showing 20 of 20.
Eugene HillVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Verified email available
Jack KenneyVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Paul LaVioletteVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Verified email available
Tom FlynnVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Elizabeth Blake SchwertVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Mike RossVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Ron HuntVerified
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Verified email available
Gregory Madden
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 63 more
Contact details available
Houman Ashrafian
Venture Capital, Investor · United Kingdom
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Michael Balmuth
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 64 more
Contact details available
Brent Faduski
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Carl Culicchia
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide and 62 more
Contact details available
Craig Slutzkin
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
James Niedel
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jeffrey Ives
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Rebecca Luse
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Vijay Lathi
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Liam Ratcliffe
Venture Capital, Angel/Individual, Investment Partner · United States
SeedHealth CareRetailBiotechnologyFinTechPortfolio: Afferent Pharmaceuticals, Shoopy, CuraSen Therapeutics, Deciphera Pharmaceuticals
Contact details available
By investment stage
- Seed8
By location
Related industries
Most-backed portfolio companies
- Direct Flow Medical17
- Karus Therapeutics17
- ReShape Lifesciences17
- CardioKinetix17
- Artios Pharma11
- CSA Medical11
- NKT Therapeutics11
- Halscion, Inc.11
- TopiVert11
- Sutro Biopharma11
- Enara Bio11
Frequently asked questions
How many Deciphera Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 20 Deciphera Pharmaceuticals investors. 6 of them (30%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (20), Private Equity Firms (10) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Deciphera Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (8).
Where are Deciphera Pharmaceuticals investors based?
Most are based in the United States (19) and the United Kingdom (1).
Which companies have Deciphera Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Direct Flow Medical (17), Karus Therapeutics (17), ReShape Lifesciences (17), CardioKinetix (17) and Artios Pharma (11).
How do I contact Deciphera Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.